![]() |
市場調查報告書
商品編碼
1797893
全球虛擬實境創傷後壓力症候群治療市場:2032 年預測 - 按組件、治療方法類型、應用、最終用戶和地區進行分析Virtual Reality Therapy for PTSD Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Service), Therapy Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球 PTSD 虛擬實境治療市場預計在 2025 年達到 15.9 億美元,到 2032 年將達到 59.4 億美元,預測期內的複合年成長率為 20.7%。
一種名為虛擬實境療法 (VRT) 的新型實證創傷後壓力症候群 (PTSD) 療法,利用身臨其境型虛擬世界,幫助患者在安全、規範的環境中面對和處理創傷記憶。在合格治療師的監督下,患者透過模擬與創傷事件極為相似的情境,逐漸接觸令人不安的刺激。這有助於情緒處理,並減輕 PTSD 症狀的嚴重程度。該方法將暴露療法的概念與虛擬體驗的有效性相結合,提供了一種客製化、更具娛樂性的替代傳統談話療法的方案。
發表在《公共科學圖書館·綜合》(PLOS ONE)上的系統綜述發現,在納入的十項研究中,有七項研究顯示,虛擬實境暴露療法 (VRET) 與觀望對照組相比,在創傷後壓力症候群 (PTSD) 症狀方面具有統計學顯著改善。這篇綜述得出結論,VRET 與傳統暴露療法同樣有效,尤其適用於對傳統療法有抵抗力的患者。
提高心理健康治療的知識和採用率
全球對創傷後壓力症候群(PTSD)等心理健康問題的認知日益加深,這推動了對虛擬實境療法等尖端且便捷的治療方法的需求。隨著圍繞精神疾病的污名逐漸消退,心理援助在公共論述中日益普及,人們尋求治療的意願也日益增強。 PTSD曾經被低估,如今在平民和軍人中都已得到普遍認可,這使得對有效且擴充性的治療模式的需求日益成長。此外,VR療法也進一步推動了這一趨勢,它提供了一種高科技、非侵入式的解決方案,既吸引了習慣使用科技的年輕一代,也吸引了尋求醫療替代方案的老年人。
缺乏臨床通訊協定和標準化
目前尚無適用於 VR 療法的 PTSD 治療的廣泛認可的臨床指南、通訊協定或標準。雖然許多臨床試驗和試點計畫已顯示出良好的結果,但研究設計、治療內容、治療持續時間和治療師參與度的差異使得結果難以比較或大規模複製。監管機構、保險公司和醫療專業人員都對這種不可預測性失去了信心。此外,缺乏標準化使得難以在不同的 VR 治療平台上保持品管,從而可能危及患者安全和治療效果。在與創傷倖存者和退伍軍人等需要定期基於研究的干涉的高危險群合作時,這個問題尤其嚴重。
擴展到平民創傷和創傷後壓力症候群治療環境
雖然我們最初的重點是軍事相關的創傷後壓力症候群 (PTSD),民營市場仍有巨大的未開發潛力。全球數百萬人因暴力犯罪、自然災害、性侵犯、事故和童年創傷而患有創傷後壓力症候群,其中許多人缺乏適當的醫療或專科護理。透過模擬適合平民的特定創傷相關場景,我們可以客製化虛擬實境療法並提供針對性治療。此外,隨著刑事司法、教育和社區健康機構對創傷知情護理的認知和接受度不斷提高,VR 治療平台擁有巨大的機會來拓展其應用範圍,並惠及更廣泛的非軍事人群。
監管和核准複雜性的地區差異
數位療法和基於虛擬實境的干涉措施在不同國家和地區仍然面臨著碎片化且不均衡的法規環境。儘管美國食品藥物管理局(FDA)等機構已開始核准一些虛擬實境治療應用,但大多數監管機構缺乏清晰的框架來評估和認證這些技術。希望進入國際市場的公司往往必須經歷繁瑣冗長的核准流程。此外,由於缺乏使用虛擬實境療法治療創傷後壓力症候群(PTSD)的國際臨床標準,這些平台更難在國際上擴張或被納入政府資助的心理健康計畫。
新冠疫情顯著加速了創傷後壓力症候群(PTSD)虛擬實境療法市場的發展,凸顯了對擴充性、技術主導的遠距心理健康解決方案的迫切需求。 VR療法已成為居家隔離期間面對面治療的可行替代方案,提供減壓技術和身臨其境型暴露療法,可透過攜帶式頭戴設備遠端進行,甚至可在臨床環境中進行。疫情加劇了心理困擾,導致醫護人員、重症疾病患者以及長期隔離或創傷的人群中PTSD病例增加。此外,心理健康服務需求的增加也為VR療法提供者提供了拓展服務範圍、與遠端醫療平台建立新的合作夥伴關係以及獲得更多資金的機會。
預計暴露療法細分市場在預測期內將佔最大佔有率
預計暴露療法將在預測期內佔據最大的市場佔有率。這種主導地位源於其堅實的臨床證據以及與身臨其境型虛擬實境環境的兼容性,這使得患者能夠透過可重複、可控的模擬來安全地處理和麵對創傷記憶。患有恐懼症和創傷相關創傷後壓力症候群 (PTSD) 的患者、退伍軍人和自然災害倖存者都將從暴露療法中受益匪淺。透過使傳統的暴露療法更加逼真和個人化,虛擬實境 (VR) 提高了患者的參與度和治療效果。在針對 PTSD 市場的虛擬實境療法中,基於 VR 的暴露療法已成為最成熟和檢驗的治療使用案例,並得到了大量臨床研究的支持,並被心理健康專業人士廣泛接受。
預計預測期內民事創傷部分將以最高的複合年成長率成長。
預計民間創傷治療領域將在預測期內呈現最高成長率。非軍事人群對心理健康問題的認知日益提高,以及與性侵犯、家庭暴力、事故和自然災害相關的創傷後壓力症候群 (PTSD) 確診病例的增加,推動了這一成長。與軍事創傷後壓力症候群 (PTSD) 不同,受疫情後壓力源影響的兒童、婦女和第一線工作人員是受民間創傷治療影響最大的人群。虛擬實境 (VR) 非常適合民用 PTSD 治療,因為它可以在受控環境中重現各種創傷場景。此外,基於 VR 的 PTSD 治療在平民中越來越受歡迎,隨著人們對心理健康的污名化逐漸減少,以及透過遠端醫療和行動VR平台獲得治療的機會不斷增加,推動了市場的顯著成長。
預計北美將在預測期內佔據最大的市場佔有率,這主要歸功於其完善的醫療保健體系、較高的創傷後壓力症候群發病率以及數位健康工具的廣泛採用。美國是該地區的領導者,這得益於對退伍軍人醫療保健的大量投資、心理健康宣導活動以及在軍事和臨床環境中採用虛擬實境療法。美國退伍軍人事務部和領先的研究型大學等組織為基於虛擬實境的創傷後壓力症候群治療的檢驗和實施提供了極大的幫助。此外,關鍵虛擬實境療法開發人員的存在和有利的報銷結構進一步鞏固了美國作為創傷後壓力症候群虛擬實境療法領先市場的地位。
預計亞太地區在預測期內將呈現最高的複合年成長率,這得益於創傷相關疾病患病率的上升、技術的快速普及以及人們對心理健康問題的認知不斷提高。政府計畫和官民合作關係正在擴大心理服務的可近性,而中國、日本、韓國和印度等國家正在大力投資數位醫療基礎設施。該地區人口眾多、智慧型手機和虛擬實境設備的普及率不斷提高以及對遠端醫療解決方案的接受度也推動了這一成長。此外,虛擬實境作為一種可擴展且經濟實惠的創傷後壓力症候群(PTSD)治療方案,正在亞太地區推廣。這是由於疫情後人們對心理健康的關注度不斷提高,以及農村地區獲得治療的難度增加。
According to Stratistics MRC, the Global Virtual Reality Therapy for PTSD Market is accounted for $1.59 billion in 2025 and is expected to reach $5.94 billion by 2032 growing at a CAGR of 20.7% during the forecast period. A new, evidence-based treatment for PTSD called virtual reality therapy (VRT) uses immersive virtual worlds to help people face and process traumatic memories in a safe and regulated environment. Under the supervision of a qualified therapist, patients are gradually exposed to upsetting stimuli by simulating situations that closely resemble the traumatic event. This helps with emotional processing and lessens the severity of PTSD symptoms. This method offers a customized and frequently more entertaining substitute for conventional talk therapy by fusing the ideas of exposure therapy with the effectiveness of virtual immersion.
According to a systematic review published in PLOS ONE, Virtual Reality Exposure Therapy (VRET) showed statistically significant improvements in PTSD symptoms compared to waitlist controls in 7 out of 10 studies reviewed. The review concluded that VRET is as effective as traditional exposure therapy and may be especially beneficial for patients resistant to conventional methods.
Growing knowledge and adoption of mental health treatments
Growing awareness of mental health issues, such as PTSD, around the world is fueling the need for cutting-edge, easily accessible treatment approaches like virtual reality therapy. Individuals are more willing to seek therapy as the stigma associated with mental illness gradually diminishes and psychological assistance becomes more commonplace in public discourse. Once underdiagnosed, PTSD is now commonly acknowledged in both civilian and military populations, and there has never been a more pressing need for effective, scalable treatment models. Additionally, this trend is supported by VR therapy, which provides a high-tech, non-invasive solution that appeals to both younger generations who are accustomed to using technology and older adults looking for alternatives to medicine.
Absence of clinical protocols and standardization
There aren't any widely recognized clinical guidelines, protocols, or standards for treating PTSD that apply to VR therapy. Although many clinical trials and pilot programs yield encouraging results, it is challenging to compare outcomes or replicate results on a large scale due to the variation in study designs, therapeutic content, treatment duration, and therapist involvement. Regulatory bodies, insurers, and medical professionals all lose faith in this unpredictability. Furthermore, lack of standardization makes it challenging to maintain quality control across various VR therapy platforms, which may jeopardize patient safety and therapeutic efficacy. This is particularly troubling when working with high-risk groups like trauma survivors or veterans, who might need regular, research-based interventions.
Extension to civilian trauma and PTSD treatment environments
Although the first focus has been on PTSD related to the military, there is a lot of unrealized potential in the civilian market. Millions of people worldwide suffer from PTSD brought on by violent crimes, natural disasters, sexual assault, accidents, or childhood trauma, but many do not receive proper or specialized treatment. By simulating particular trauma-related settings that are pertinent to civilian populations, virtual reality therapy can be customized to provide targeted treatment. Moreover, VR therapy platforms have a great chance to broaden their applications and reach more people outside of the military as criminal justice, education, and community health settings become more conscious of and accepting of trauma-informed care.
Regional differences in regulatory and approval complexities
Digital therapies and VR-based interventions continue to face a fragmented and uneven regulatory environment across various nations and regions. The majority of regulatory bodies lack clear frameworks for assessing and certifying these technologies, even though organizations like the U.S. FDA are starting to approve some VR therapy applications. Businesses that want to expand into foreign markets frequently have to deal with onerous and drawn-out approval a procedure, which adds to expenses and raises legal questions. Furthermore, it is more difficult for platforms to expand internationally or be incorporated into government-funded mental health programs when there are no international clinical standards for the use of VR therapy in the treatment of PTSD.
The market for virtual reality therapy for PTSD was greatly accelerated by the COVID-19 pandemic, which brought attention to the pressing need for scalable, technology-driven, remote mental health solutions. VR therapy became a feasible substitute for in-person therapy sessions during lockdowns, providing stress-reduction techniques and immersive exposure therapy that could be administered remotely via portable headsets or even in clinical settings. PTSD cases among healthcare workers, survivors of severe illness, and people who have experienced prolonged isolation or trauma have increased as a result of the pandemic's escalation of psychological distress. Moreover, the increased demand for mental health services gave VR therapy providers the chance to broaden their services, establish new alliances with telehealth platforms, and secure more funding.
The exposure therapy segment is expected to be the largest during the forecast period
The exposure therapy segment is expected to account for the largest market share during the forecast period. This dominance is a result of its solid clinical basis and compatibility with immersive virtual reality environments, which enable patients to safely process and confront traumatic memories through repeatable, controlled simulations. People with PTSD that is phobia- or trauma-related, combat veterans and survivors of natural disasters all benefit greatly from exposure therapy. By making traditional exposure more realistic and personalized, virtual reality (VR) improves patient engagement and treatment results. Within the PTSD market for virtual reality therapy, VR-based exposure therapy has emerged as the most well-established and validated therapeutic use case, supported by a wealth of clinical research and widely embraced by mental health practitioners.
The civilian trauma segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the civilian trauma segment is predicted to witness the highest growth rate. Rising awareness of mental health concerns among non-military populations and an increase in PTSD diagnoses connected to sexual assault, domestic abuse, accidents, and natural disasters are driving this growth. Children, women, and frontline workers impacted by post-pandemic stressors are among the larger demographics affected by civilian trauma, in contrast to military PTSD. Virtual reality is ideally suited for treating civilian PTSD due to its ability to replicate a variety of trauma scenarios in a controlled environment. Moreover, VR-based PTSD treatment is becoming increasingly popular among civilians, which is propelling significant market growth as mental health stigma decreases and access to therapy increases through telehealth and mobile VR platforms.
During the forecast period, the North America region is expected to hold the largest market share, mainly because of its sophisticated healthcare system, high PTSD rate, and robust use of digital health tools. Due to large investments in veteran healthcare, mental health awareness initiatives, and the incorporation of virtual reality therapy into military and clinical settings, the United States is the region leader. The validation and implementation of VR-based PTSD treatments have been greatly aided by organizations like the U.S. Department of Veterans Affairs and top research universities. Additionally, North America's position as the leading market for VR therapy aimed at PTSD is further reinforced by the existence of significant VR therapy developers and advantageous reimbursement structures.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by a rise in the prevalence of trauma-related disorders, a rapid adoption of technology, and a growing awareness of mental health issues. While government programs and public-private partnerships are increasing access to psychological services, nations such as China, Japan, South Korea, and India are making significant investments in digital healthcare infrastructure. The surge is also attributed to the region's large population, increasing use of smartphones and virtual reality devices, and receptiveness to telemedicine solutions. Furthermore, VR is being promoted as a scalable and affordable PTSD treatment option throughout Asia-Pacific due to the post-pandemic emphasis on mental wellness and the difficulty of accessing therapy in rural areas.
Key players in the market
Some of the key players in Virtual Reality Therapy for PTSD Market include Psious Inc, AppliedVR Inc., XRHealth Inc., Oxford VR, Pear Therapeutics, Virtually Better, Inc., BehaVR, MindMaze Inc, Cognihab, Realiteer, Limbix, Emteq Labs and ImmersiveTouch Inc.
In February 2025, XRHealth, a provider of therapeutic virtual reality (VR), mixed reality (MR), and extended reality (XR) solutions, has this week announced that it has acquired digital therapeutics company RealizedCare. Outcome Capital served as strategic and financial advisor for the acquisition. The RealizedCare platform of immersive digital therapeutics addresses chronic pain and mental health challenges through evidence-based CBT and biopsychosocial protocols.
In July 2024, ImmersiveTouch Inc announced that its groundbreaking augmented reality (AR) technology platform, ImmersiveAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The Chicago-based company will commence immediate commercialization of the platform in the United States.
In November 2023, BehaVR and Fern Health announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.